Remember the biotech bubble talk? As we mentioned in our Market News section in March 2014, there never was a bubble. Bearish fools were convinced the end was nigh for biotech names, we noted at the time. They even talked down the iShares NASDAQ Biotechnology ETF (IBB) from $270 to less than $210 in no…
DetailsThis is the biggest, most important market story today. It’s probably the biggest story of the decade. It’s filled with so many clues as to where the markets are headed in the next year, two years, five years and more. As usual, no one is paying attention at all. And that’s why we’re going over…
DetailsMorgan Stanley made a bold prediction yesterday. The bank said combination of economic growth and low interest rates would propel S&P 500 would peak at 3,000 within three years. If it does, the Dow would be right around 25,000. Seems bold right? Well, it’s not. After all, the S&P would only have to return 7%…
DetailsMost of the world’s top stock investors aren’t great market timers. They couldn’t pick the top of bottom of any market cycle. They don’t even try. But they do study history of market cycles, have a deep understanding of them, and move in when things are bad and out when they’re good. That’s why some…
DetailsIf you like gold, you’ve got to love gold mining stocks. That’s what I wrote to you and your fellow Profit Alert readers back in May. Since then gold stocks have been quietly one of the brightest spots in the market. All gold stocks have done well lately. Up about 30% across the board. And…
DetailsWhat I’m about to show you is the scariest chart in all of finance. It portends a horrific ending to the current boom in stocks, bonds, real estate. It, however, also shows a big opportunity for investors right now. In fact, there’s news today about one billionaire is positioning himself to make another fortune as…
DetailsIt really shouldn’t be this easy… For months, the fools said the “biotech bubble” was popping. It’s over, they’d say. There was just one problem. There never was a bubble. As we noted on March 25, 2014, “This year, bearish fools may have convinced the herd that the end is nigh for biotech names. They…
DetailsA funny thing happened after we disagreed with Apple and palladium metal bulls. We were called foolish. “Apple is going up from here,” noted one reader. “You can’t ignore Apple under $100. This is a steal.” Another said, “Palladium will continue moving higher. I don’t think you’re paying attention.” But we were. We knew exactly…
Details“What’s your take on the price of palladium,” asks Cheap Investor reader Scott. “Should I buy related stocks?” To be completely honest, buy only if you like losing money. The bulls have gotten ahead of themselves again. The metal may be under very heavy demand with little supply. But it’s only appreciating this fast because…
Details“I’ve really enjoyed my subscription to The Cheap Investor,” notes Marc C. “I just wanted to know if you would buy Apple under $100 here.” In short, no… Even after the 7:1 split, Apple is still over-extended at historical resistance. It may seem like a steal with an 85% haircut, but it’s not. It’s still…
DetailsFellow Cheap Investor reader Don B. asks, “can you still buy Patriot Coal shares now that the company is bankrupt?” At the moment, we don’t believe shares can be bought. It last traded on December 18, 2013. There’s no volume. There’s no interest. In July 2012, the company field for bankruptcy protection because of struggles…
Details“It looks like you called the bottom on copper perfectly,” notes fellow Cheap Investor reader, Susan T. “I even bought into the stocks you said may do well and walked with some good gains on Southern Copper and Freeport. Thank you.” Copper was never going to move much lower than 290. We knew that just…
Details
